All Stories

  1. Biomarker Profiling of Upper Tract Urothelial Carcinoma Only and with Synchronous or Metachronous Bladder Cancer
  2. Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS Syndrome
  3. Cellular iron governs the host response to malaria
  4. Generation of an Obese Diabetic Mouse Model upon Conditional Atrx Disruption
  5. Renovascular Hypertension: Unraveling a Case of Mixed Histiocytosis
  6. Cellular iron governs the host response to malaria
  7. Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
  8. An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms
  9. Clinicopathological features of head and neck cutaneous basal cell carcinoma observed at the Centro Hospitalar de Trás-os-Montes e Alto Douro ENT Department
  10. Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
  11. Primary adrenal angiosarcoma within a hematoma
  12. Connexin Expression in Pituitary Adenomas and the Effects of Overexpression of Connexin 43 in Pituitary Tumor Cell Lines
  13. Colonic Pseudolipomatosis: A Rare and Challenging Condition
  14. Predictive Biomarkers in Melanoma: Detection of BRAF Mutation Using Dermoscopy
  15. <b><i>TERT</i></b> Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy
  16. TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features
  17. Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
  18. The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
  19. LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
  20. Mohs Micrographic Surgery for Head and Neck Nonmelanoma Skin Cancer: An Approach for Ent Surgeons
  21. Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
  22. Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas
  23. Metabolic modulation combined with mTOR pathway inhibition may overcame cutaneous melanoma resistance to MAPK inhibitors treatment
  24. Embryonal Tumors of the Central Nervous System
  25. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
  26. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
  27. Erratum to “Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism”
  28. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study
  29. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
  30. A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome
  31. Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?
  32. Juvenile gangrenous vasculitis of the scrotum – a diagnosis not to forget
  33. Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2
  34. Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
  35. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  36. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  37. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
  38. Periocular Sebaceous Carcinoma With Apocrine Differentiation: A Case Report and Review of the Literature
  39. Histological Subtypes and Clinical Behavior Evaluation of Salivary Gland Tumors
  40. The genetics of cutaneous squamous cell carcinogenesis
  41. An unusual case of epistaxis due to angiofibroma of the nasal cavity
  42. Cutaneous amyloidosis as major manifestation of systemic AL-amyloidosis
  43. Melanoma treatment in review
  44. Telomere Maintenance Mechanisms in Cancer
  45. Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas
  46. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
  47. Malignant Solitary Fibrous Tumor of the Liver:AIRP Best Cases in Radiologic-Pathologic Correlation
  48. Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions
  49. Primary intimal sarcoma of the left atrium presenting with constitutional symptoms
  50. SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
  51. Epigenetics in endometrial carcinogenesis – part 2: histone modifications, chromatin remodeling and noncoding RNAs
  52. Epigenetics in endometrial carcinogenesis – part 1: DNA methylation
  53. The role of pathology in the management of patients with endometrial carcinoma
  54. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
  55. Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer
  56. Adipose Tissue Tumors, Stomach
  57. C-Kit (CD117), Gastrointestinal Stromal Tumors (GISTs)
  58. Distant Metastases in Uterine Leiomyosarcomas
  59. Gastrointestinal Autonomic Nerve Tumor
  60. Gastrointestinal Stromal Tumor
  61. Glomus Tumor, Gastrointestinal
  62. Granular Cell Tumor, Gastrointestinal
  63. Inflammatory Fibroid Polyp, Upper Gastrointestinal Tract
  64. Inflammatory Myofibroblastic Tumor, Upper Gastrointestinal Tract
  65. Neuroendocrine Tumor, Esophagus
  66. Neuroendocrine Tumor, Gastric
  67. Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
  68. Neurocristic hamartoma of the scalp
  69. Solitary squamoid cyst of the liver
  70. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome
  71. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
  72. Spitz/Reed nevi: a review of clinical-dermatoscopic and histological correlation
  73. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
  74. Metanephric adenoma: Cytological, histological, and molecular diagnosis of a case
  75. Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception
  76. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium
  77. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes
  78. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management
  79. “A book should not be judged by its cover”: two cases of intestinal adenocarcinoma as the first manifestation of Crohn’s disease
  80. Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors
  81. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
  82. LÚPUS ERITEMATOSO CUTÂNEO - CORRELAÇÃO CLÍNICOPATOLÓGICA DE MANIFESTAÇÕES CUTÂNEAS ESPECÍFICAS
  83. RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
  84. Endometrial Carcinoma in Portugal
  85. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
  86. Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline
  87. Pathology, therapy and prognosis of papillary renal carcinoma
  88. AIRP Best Cases in Radiologic-Pathologic Correlation: Gastroblastoma: A Rare Biphasic Gastric Tumor
  89. Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)
  90. Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial
  91. TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
  92. Telomerase promoter mutations in cancer: an emerging molecular biomarker?
  93. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas
  94. Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva
  95. PNET with neuroendocrine differentiation of the lung
  96. Tactoid body features in a Schwann cell hamartoma of colonic mucosa
  97. Frequency of TERT promoter mutations in human cancers
  98. GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
  99. Feasibility of Fine-Needle Aspiration in the Diagnosis of Two Unusual Childhood Jaw Tumor Types: Prognoma and Cementifying Fibroma
  100. Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature
  101. Multiple Hepatic Inflammatory Pseudotumours Diagnosed after Laparoscopic Excisional Biopsy
  102. Simultaneous presentation of Kaposi sarcoma and HHV8-associated large B-cell lymphoma in the same lymph node: A rare diagnosis in an HIV-negative patient
  103. Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness
  104. Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma
  105. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors
  106. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature
  107. mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
  108. 295 Protein Kinase WNK2 Was Correlated With Poor Outcome and Malignant Behavior in Glioma Cell Lines
  109. Insights into melanoma: targeting the mTOR pathway for therapeutics
  110. The mTOR Signalling Pathway in Human Cancer
  111. Melanocytic Tumour in a Black Sheep never exposed to Ultraviolet Radiation
  112. Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
  113. A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease
  114. Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review
  115. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms
  116. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
  117. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
  118. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
  119. ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
  120. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
  121. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad
  122. Abdominal inflammatory myofibroblastic tumor
  123. Endometrial Carcinomas
  124. Ascites as a Presenting Sign of Disseminated Tuberculosis in an Immunocompetent Patient
  125. Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome
  126. Plenary Oral Free Paper Sessions
  127. Black esophagus
  128. Human Endometrium Ultrastructure During the Implantation Window
  129. Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses
  130. Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification
  131. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics
  132. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
  133. Idiopathic Infantile Arterial Calcification: A Rare Cause of Sudden Unexpected Death in Childhood
  134. 78 Analysis of raf kinase inhibitor protein (RKIP) expression as a prognostic marker for glioblastomas
  135. 95 Associations between functional EGFR polymorphisms and glioma risk
  136. Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours
  137. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
  138. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma
  139. Angiogenesis and Breast Cancer
  140. ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
  141. ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
  142. ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors
  143. Effects of Diabetes Mellitus, Pressure-Overload and Their Association on Myocardial Structure and Function
  144. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
  145. Loss of RKIP expression is associated with poor survival in GISTs
  146. Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation
  147. Low frequency of MAP kinase pathway alterations inKITandPDGFRAwild-type GISTs
  148. Low-Grade Endometrial Stromal Sarcoma and Undifferentiated Endometrial Sarcoma: A Comparative Analysis Emphasizing the Importance of Distinguishing Between These Two Groups
  149. TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
  150. Restrictive dermopathy—a lethal congenital laminopathy. Case report and review of the literature
  151. Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma
  152. 583 POSTER Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs
  153. Clinicopathological features of 45,X/46,Xidic(Y) mosaicism and therapeutic implications: case report
  154. Surgical Margin Status and Prognosis of Gastrointestinal Stromal Tumor
  155. Clear Cell Change in Colonic Polyps
  156. Composite Adenomatoid Tumor and Myelolipoma of Adrenal Gland: Report of 2 Cases
  157. Epithelial-myoepithelial parotid carcinoma after kidney transplantation
  158. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas
  159. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
  160. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma
  161. Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary
  162. Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin
  163. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma
  164. Splenic hamartomas in a dog
  165. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series
  166. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
  167. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation
  168. Association between Functional EGF+61 Polymorphism and Glioma Risk
  169. Multiple Myeloma Presenting with Malabsorption
  170. Gastrinoma (Duodenal and Pancreatic)
  171. Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
  172. Rare Functioning Pancreatic Endocrine Tumors
  173. Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)
  174. Well-Differentiated Gastric Tumors/Carcinomas
  175. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
  176. Orbital Metastasis as a Rare Form of Clinical Presentation of Non-small Cell Lung Cancer
  177. Deep-Seated Congenital Juvenile Xanthogranuloma
  178. Determining the least time required for measuring energy expenditure in premature neonates
  179. 183 POSTER Molecular alterations of KIT and PDGFR-alpha; in GISTs - A Portuguese experience
  180. Fluid supplementation for neonatal hyperbilerubinemia
  181. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
  182. Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen
  183. Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
  184. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors
  185. Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum
  186. Gingival Hyperplasia as a First Manifestation of Crohn's Disease
  187. Colonic Gastrointestinal Autonomic Nervous Tumor in a Patient with Crohn’s Disease
  188. Esophageal Gist: Therapeutic implications of an uncommon presentation of a rare tumor
  189. Epithelioid hemangioendothelioma and multiple thoraco-lumbar lateral meningoceles: two rare pathological entities in a patient with NF-1
  190. Mutation analysis of B-RAF gene in human gliomas
  191. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma
  192. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia
  193. Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid
  194. Pathologic Quiz Case: A 53-Year-Old Man With a Slowly Enlarging Mass in the Right Leg
  195. Cutaneous Malignant Melanoma: The Great Simulator
  196. Expression of c-met Tyrosine Kinase Receptor Is Biologically and Prognostically Relevant for Primary Cutaneous Malignant Melanomas
  197. Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations
  198. Classic Kaposi's sarcoma of the tongue: Case report with emphasis on the differential diagnosis
  199. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  200. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
  201. Carcinoma secretor da mama no adulto: existem parâmetros bem definidos para decisão terapêutica?
  202. Congenital composite hemangioendothelioma: case report and reappraisal of the hemangioendothelioma spectrum
  203. Response to Cyclosporine in a Patient With Disseminated Granuloma Annulare Associated With CD4+/CD8+(dim)/CD56+ Large Granular Lymphocytic Leukemia
  204. Chronic Eosinophilic Leukaemia Presenting with Erythroderma, Mild Eosinophilia and Hyper-IgE: Clinical, Immunological and Cytogenetic Features and Therapeutic Approach
  205. Hyaline Cell-rich Chondroid Syringoma: Case Report and Review of the Literature
  206. Cutaneous alternariosis by Alternaria chartarum in a renal transplanted patient
  207. Primary acinic cell-like carcinoma of the breast-a variant with good prognosis?
  208. Genetic Profile of Gliosarcomas
  209. Adenocarcinoma of the cervix
  210. Microsatellite instability is not associated with degree of malignancy and p53 expression of gastrointestinal stromal tumours
  211. Time of remodelling of the patella tendon graft in anterior cruciate ligament surgery: an histological and immunohistochemical study in a rabbit model
  212. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
  213. Synovial sarcoma: immunohistochemical expression of p-glycoprotein and glutathione s-transferase-pi and clinical drug resistance
  214. Critical Commentary
  215. Critical Commentary
  216. Proliferative Activity of Synovial Sarcoma: An Immunohistochemical Evaluation of Ki-67 Labeling Indices of 52 Primary and Recurrent Tumors
  217. Immunohistochemical Profile of Synovial Sarcoma with Emphasis on the Epithelial-type Differentiation
  218. Phacolytic glaucoma and lens-induced uveitis
  219. Critical Commentary
  220. Critical Commentary
  221. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
  222. The Ultrastructural Spectrum of Synovial Sarcomas: A Study of the Epithelial Type Differentiation of Primary Tumors, Recurrences, and Metastases
  223. Congenital Hereditary Corneal Dystrophy: Histologic and Ultrastructural Assessment of a Peculiar Polimorphic Recessive Form
  224. Dermatofibrosarcoma Protuberans
  225. Round cell sarcoma after clear cell sarcoma remission
  226. Thymic Tumors
  227. Abnormal Organization of the Human Retina in a Genetic Disorder (Bloch-Sulzberger Syndrome)
  228. Cytogenetic study of a sclerosing stromal tumor of the ovary
  229. Common arterial trunk associated with absence of one atrioventricular connexion